This company listing is no longer active
Dingdang Health Technology Group Past Earnings Performance
Past criteria checks 0/6
Dingdang Health Technology Group's earnings have been declining at an average annual rate of -0.9%, while the Consumer Retailing industry saw earnings growing at 18.3% annually. Revenues have been growing at an average rate of 6.3% per year.
Key information
-0.9%
Earnings growth rate
26.7%
EPS growth rate
| Consumer Retailing Industry Growth | 28.3% |
| Revenue growth rate | 6.3% |
| Return on equity | -10.5% |
| Net Margin | -4.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Dingdang Health Technology Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 4,877 | -198 | 1,756 | 59 |
| 31 Mar 24 | 4,867 | -212 | 1,740 | 62 |
| 31 Dec 23 | 4,857 | -226 | 1,724 | 65 |
| 30 Sep 23 | 4,722 | -1,297 | 1,690 | 69 |
| 30 Jun 23 | 4,587 | -2,368 | 1,655 | 73 |
| 31 Mar 23 | 4,465 | -2,491 | 1,670 | 82 |
| 31 Dec 22 | 4,329 | -2,833 | 1,687 | 89 |
| 30 Sep 22 | 4,177 | -1,951 | 1,780 | 93 |
| 30 Jun 22 | 4,025 | -1,069 | 1,873 | 96 |
| 31 Mar 22 | 3,886 | -1,232 | 1,844 | 99 |
| 31 Dec 21 | 3,679 | -1,578 | 1,727 | 96 |
| 31 Dec 20 | 2,229 | -924 | 838 | 82 |
| 31 Dec 19 | 1,276 | -277 | 531 | 52 |
| 31 Dec 18 | 585 | -108 | 272 | 31 |
Quality Earnings: 9886 is currently unprofitable.
Growing Profit Margin: 9886 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9886 is unprofitable, and losses have increased over the past 5 years at a rate of 0.9% per year.
Accelerating Growth: Unable to compare 9886's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 9886 is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (-8.4%).
Return on Equity
High ROE: 9886 has a negative Return on Equity (-10.47%), as it is currently unprofitable.